Leucrotta Exploration (LXE) Price Target Lowered to C$1.25 at Canaccord Genuity

Share on StockTwits

Leucrotta Exploration (CVE:LXE) had its price target trimmed by Canaccord Genuity from C$2.00 to C$1.25 in a report published on Thursday.

LXE has been the topic of several other research reports. Royal Bank of Canada cut their price target on Leucrotta Exploration from C$2.50 to C$2.00 and set an outperform rating on the stock in a research note on Thursday, November 29th. Cormark cut their target price on Leucrotta Exploration from C$3.00 to C$2.60 in a research note on Thursday, November 29th. CIBC cut their target price on Leucrotta Exploration from C$2.00 to C$1.60 in a research note on Thursday, November 29th. Desjardins cut their target price on Leucrotta Exploration from C$2.75 to C$2.25 in a research note on Thursday, November 29th. Finally, Raymond James set a C$2.45 target price on Leucrotta Exploration and gave the company an outperform rating in a research note on Friday, November 23rd.

Shares of Leucrotta Exploration stock traded up C$0.03 during midday trading on Thursday, hitting C$1.09. The company had a trading volume of 65,597 shares, compared to its average volume of 76,722. Leucrotta Exploration has a 52-week low of C$0.86 and a 52-week high of C$2.12.

Leucrotta Exploration Company Profile

Leucrotta Exploration Inc operates as an oil and natural gas company. The company acquires, explores for, develops, and produces oil and natural gas reserves in northeastern British Columbia, Canada. It holds interest in approximately 100,500 gross acres of Montney land in Doe/Mica. Leucrotta Exploration Inc was incorporated in 2014 and is based in Calgary, Canada.

See Also: Momentum Indicator: Relative Strength Index

Receive News & Ratings for Leucrotta Exploration Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leucrotta Exploration and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Biocept  Shares Gap Down to $1.67
Biocept Shares Gap Down to $1.67
VirnetX  Shares Gap Up to $6.33
VirnetX Shares Gap Up to $6.33
Zacks: Brokerages Anticipate Repligen Co.  Will Post Quarterly Sales of $50.33 Million
Zacks: Brokerages Anticipate Repligen Co. Will Post Quarterly Sales of $50.33 Million
Stealth 24-Hour Volume Tops $138.00
Stealth 24-Hour Volume Tops $138.00
Molecular Future  1-Day Volume Tops $421,889.00
Molecular Future 1-Day Volume Tops $421,889.00
Deutsche Lufthansa AG  Receives Consensus Recommendation of “Hold” from Brokerages
Deutsche Lufthansa AG Receives Consensus Recommendation of “Hold” from Brokerages


Leave a Reply

© 2006-2019 Ticker Report